Mankind Pharma (NSE:MANKIND) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MANKIND Mankind Pharma Ltd NSE:MANKIND
91 GF Score
Price ₹2,425.20
GF Value ₹2,948.17
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Mankind Pharma FFO?

FFO (Funds from operations) only applies to REITs.

NSE:MANKIND
91GF Score
Mankind Pharma Ltd NSE:MANKIND
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mankind Pharma (NSE:MANKIND) Overvalued in 2026?

Based on GuruFocus' analysis, Mankind Pharma stock appears to be undervalued. The current stock price of ₹2,425.20 is trading 17.7% below its estimated GF Value™ of ₹2,948.17. GuruFocus considers Mankind Pharma to be Modestly Undervalued.

Key valuation signals for NSE:MANKIND:

  • FFO:
  • GF Value™: ₹2,948.17 vs. price of ₹2,425.20 (17.7% below fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the NSE:MANKIND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mankind Pharma Business Description

Other Exchanges 543904:India
Address 262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Mankind Pharma Ltd is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors providing products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News, Gas-O-Fast, AcneStar and HealthOK. Geographically, the company derives a majority of its revenue from the sale of pharmaceutical products in India and the rest from its customers located outside India.
91GF Score

Get the complete analysis for NSE:MANKIND

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,425.20
Price
₹2,948.17
GF Value